Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

What's Behind 10x Genomics' Acquisition Strategy?

TheMotleyFool

0 0

What's Behind 10x Genomics' Acquisition Strategy?

10x Genomics (NASDAQ: TXG) has gobbled up several smaller companies over the last year. These deals have extended the company's offerings and expanded its addressable market in some cases. In this video recorded on March 11, 2021, Motley Fool contributor Keith Speights talks with 10x Genomics CEO and co-founder Serge Saxonov about his company's acquisition strategy.

Source Fool.com

Like: 0

TXG

Share